{
    "title": "Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation",
    "abstract": "arXiv:2311.10879v2 Announce Type: replace-cross  Abstract: Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of p",
    "link": "https://arxiv.org/abs/2311.10879",
    "context": "Title: Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation\nAbstract: arXiv:2311.10879v2 Announce Type: replace-cross  Abstract: Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of p",
    "path": "papers/23/11/2311.10879.json",
    "total_tokens": 857,
    "translated_title": "改进乳腺MRI肿瘤分割的前后对比合成",
    "translated_abstract": "尽管动态增强MRI（DCE-MRI）中对比剂的使用对于肿瘤的检测和治疗有益处，但存在一系列问题，包括其侵入性、生物积累性及潜在的肾源性系统纤维化风险。本研究探讨了通过将术前对比前T1加权脂肪饱和乳腺MRI转换为其对应的首次DCE-MRI序列，利用生成对抗网络（GAN）的能力来产生合成对比增强的可行性。此外，我们引入了一种用于定量评估合成数据质量的比例聚合测量（SAMe），并作为选择最佳生成模型的基础。我们使用定量图像质量指标评估生成的DCE-MRI数据，并将其应用于3D乳腺肿瘤分割的下游任务。我们的结果突显了p的潜力",
    "tldr": "通过生成对抗网络（GAN）在乳腺MRI中合成对比增强，引入了Scaled Aggregate Measure (SAMe)进行量化评估，并成功应用于乳腺肿瘤分割任务。",
    "en_tdlr": "Synthesizing contrast enhancements in breast MRI using Generative Adversarial Networks (GAN), introducing Scaled Aggregate Measure (SAMe) for quantitative evaluation, successfully applied in breast tumor segmentation."
}